Logo

LevitasBio: Dominique Remy-Renou, Greg Herrema

Nov 28, 2022

LevitasBio said that Dominique Remy-Renou has joined the company as senior VP of global commercial operations at LevitasBio Europe. She has previously served as CEO of Genomic Vision, VP of commercial operations at Fluidigm, president and general manager at Pacific Biosciences, and senior director of marketing for Europe at Applied Biosystems.

In addition, Greg Herrema has joined LevitasBio's board of directors. He was previously president of Thermo Fisher Scientific's Fisher Scientific and Fisher Healthcare Channels business, president of the firm's bioscience business, and president of its analytical instruments business.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.